Cannabidiol (CBD) Pet Market Analysis

CBD Pet Market Analysis

To get key market trends

  Download Free Sample

Based on the pet type, the market is categorized into cats, dogs, and other pet types. The dogs segment is set to lead the market, accounting for the largest revenue of USD 416.1 million in 2023, anticipating its dominance throughout the forecast period with a significant growth rate.

• The dominance was attributed to the increasing popularity of dogs as pets globally. Dogs are more widely adopted and have a higher demand for CBD products due to various health issues such as osteoarthritis, hip dysplasia, and chronic diseases.

   

• The growing awareness of CBD's therapeutic benefits among dog owners and the availability of a wide range of CBD products including supplements, further contribute to the dominance of the dogs segment in the market. For instance, in March 2024, CV Sciences, Inc. launched new CBD-infused chews specifically designed for pets, including +PlusCBD Pet Hip and Joint Health Chews for dogs and +PlusCBD Pet Calming Care Chews for pets. These products are intended to target prevalent health concerns among dogs, such as joint pain and anxiety. This introduction expands CV Sciences' product range in the market, aiming to meet the growing demand for natural solutions to improve pet health.

Based on product type, the CBD pet market is classified into therapeutics and supplements. The supplements segment holds the largest market share of 62.7% in 2023 and is expected to maintain dominance throughout the analysis period.

• The dominance is attributed to the increasing demand for CBD supplements among pet owners, seeking to enhance their pets' health. CBD supplements support cerebral stimulation, reduce boredom, and ease anxiety in pets, making them a popular choice for pet owners. The supplements are widely available in various forms like chews, treats, drops, and solutions.

   

• Thus, the wide acceptance of supplements for pet care aimed to witness the segment dominance in the market.

   

Based on application, the CBD pet market is segmented into pain management, anxiety and stress relief, joint health and mobility, skin and allergies, and other applications. The joint health and mobility segment is expected to exhibit a CAGR of 18% during the analysis period.

• Joint health and mobility dominated the market due to the increasing prevalence of joint-related issues in pets. Osteoarthritis, hip dysplasia, and joint inflammation are common conditions affecting dogs and cats, leading to chronic pain and discomfort. Therefore, CBD products have been found to effectively alleviate these symptoms by reducing inflammation, promoting joint health, and improving mobility.

   

• For instance, according to the Companion Animal Health report, Osteoarthritis accounts for at least 80% of lameness and joint disease cases in pets. While osteoarthritis is often linked with older animals, a recent study on its prevalence and clinical signs in young dogs (aged 8 months to 4 years) revealed that 39.8% of these animals exhibited radiographic signs of osteoarthritis in at least one joint. This highlighted the significant impact of osteoarthritis across various age groups in pets, underscoring the need for effective treatments. Therefore, the increased demand for effective treatments for managing joint health aimed to drive market expansion.

   

Based on the distribution channel, the cannabidiol pet market is segmented into pet specialty stores, CBD stores, E-commerce, and other distribution channels. The E-commerce is projected to reach USD 1.3 billion by 2032.

• E-commerce platforms provide pet owners with a variety of products, and additionally offer seasonal discounts and promotions. Also, CBD product developers are increasingly collaborating with e-commerce platforms to reach a wider customer base and make their products more accessible to pet owners worldwide.

   

• For instance, in 2021, Pet Releaf entered into a partnership with Alphagreen to broaden the online distribution of its CBD pet products across Europe. Alphagreen, a prominent health and wellness e-commerce platform, features over 250 brands and nearly 2,000 products catering to European consumers. This collaboration enables Alphagreen to offer a complete range of Pet Releaf products within its portfolio, significantly expanding the accessibility of CBD pet products throughout Europe.

The U.S. dominated the North American CBD pet market accounting for USD 384.9 million in 2023 and is anticipated to show significant growth over the analysis period.

• The U.S. boasts a large population of pet dogs and cats with millions of households owning at least one canine and feline as a companion. For instance, an article published by My Golden Retriever Puppies in August 2023, reported that dogs and cats are globally cherished and widely favored as pets, with the U.S. alone hosting an estimated 89.7 million pet dogs. This high pet ownership rate created a substantial market for therapeutic and pet supplements including CBD products, thereby driving the market demand.

   

• In addition, growing regulatory support towards hemp-derived products contributes to the market-driving demand. For instance, the Farm Bill federally legalized hemp by removing it from the controlled substances list. This enabled the production and sale of hemp-derived CBD products, permissible if containing less than 0.3% THC. This resulted in increased development and marketing of CBD products for both humans and pets, significantly expanding the market.

   

• Further, the presence of leading companies and innovative research in the U.S. also contributes to its dominance, with the country often being at the forefront of advancements in pet care products. Such aforementioned factor is expected to spur the country-level market growth.

   

Germany exhibited a high growth potential in the European CBD pet market.

• Germany plays a significant role in the European CBD pet market due to its large pet population coupled with extensive scientific research, innovation, and development in animal health. For instance, the country has 34.7 million pets, with approximately 47 percent of German households being home to pets. Notably, 15 percent of these households are multi-pet households, demonstrating a significant market potential for pet-related products and services in Germany. Thus, the high pet population drives increased demand for pet products, including CBD pet products, reflecting a growing market trend.

   

The Asia Pacific CBD pet market is poised for rapid growth with a CAGR of 19% during the forecast period.

• Asia Pacific exhibited substantial growth in the market due to increasing pet ownership, rising disposable incomes, and evolving attitudes toward pet healthcare contributing to the region's expanding market. Also, regulatory changes favoring CBD use in pet products in countries such as Japan and South Korea is expected to propel the regional market growth.

   

• Further, the growing trends in pet care and wellness drive the adoption of CBD products, positioning Asia Pacific as a key growth area in the global market.